专利检索 ap:"John M. Amatruda" 第 1 页

1.

发明申请
Combination of a Dipeptidyl Peptidase-IV Inhibitor and a Cannabinoid CB1 Receptor Antagonist for the Treatment of Diabetes and Obesity 审中-公开
标题翻译：联合二肽基肽酶-IV抑制剂和大麻素CB1受体拮抗剂治疗糖尿病和肥胖

公开(公告)号：US20090306037A1

公开(公告)日：2009-12-10

申请号：US11919308

申请日：2006-04-28

申请人： John M. Amatruda , Tung M. Fong , David E. Moller , Nancy A. Thornberry

发明人： John M. Amatruda , Tung M. Fong , David E. Moller , Nancy A. Thornberry

IPC分类号： A61K31/4985 , A61P3/06 , A61P3/10

CPC分类号： A61K31/4709 , A61K31/4985 , A61K2300/00

摘要： The present invention relates to pharmaceutical compositions comprising a combination of a particular dipeptidyl peptidase-IV (DPP-IV) inhibitor and a particular cannabinoid CB?1#191 receptor antagonist/inverse agonist, kits containing such combinations and methods of using such compositions for the treatment of diabetes, diabetes associated with obesity, diabetes-related disorders, obesity, and obesity-related disorders.

摘要翻译： 本发明涉及包含特定二肽基肽酶-IV（DPP-IV）抑制剂和特定大麻素CB 1＃191受体拮抗剂/反向激动剂的组合的药物组合物，其含有这些组合的试剂盒和使用该组合物的方法用于治疗糖尿病，与肥胖相关的糖尿病，糖尿病相关疾病，肥胖症和肥胖相关疾病。